期刊文献+

改良高效液相色谱荧光检测法测定人血浆氢溴酸加兰他敏浓度 被引量:4

Improvement of detection limit in HPLC determination of galantamine in plasma
下载PDF
导出
摘要 目的:改进高效液相色谱荧光法测定人血浆中氢溴酸加兰他敏浓度的方法,提高其灵敏度和精确度。方法:采用Hypersil-C_8色谱柱,以乙腈-水(30:70)作为流动相(pH=5.9,含三乙胺0.2%)。碱化血浆后经无水乙醚2次提取,合并2次提取的有机层,挥干乙醚后,残渣经溶有参照标准品阿替洛尔的流动相溶解后进行测定。荧光检测的激发波长为290nm,发射波长为320nm。结果:本法测定氢溴酸加兰他敏的线性范围为1~50μg·L^(-1)(r=0.999),最低检测限0.2ng,最低检测浓度为1μg·L^(-1)。日内变异系数为11.86%,日间变异系数为8.40%,萃取回收率和方法回收率均>80%。1μg·L^(-1)的回收率大于60%。结论:本方法精密、准确,适用于加兰他敏的临床检测。 Objective:To improve the detection limit in HPLC determination of galantamine in plasma. Methods:The alkalized plasma sample was extracted with absolute ether for twice, combined the extracts, after evaporation of ether the residue was dissolved by mobile phase with dissolved atenolol reference standard. After treatment,the sample was injected into the hypersil-C8 reverse phase column. The mobile phase consisted of acetonitrile-H2O (30:70) with 0.2% triethylamine and its pH was adjust to 5.9 with HAC,and the fluorescence detector was set as follows;EX 290nm and EM 320nm. Results : A liner range of 1 - 50μg · L -1 ( r = 0. 999) ,a minimum detectable limit of 0. 2ng, a minimum detectable concentration of 1μg·L-1, a recovery of >80% were obtained in this analysis. The intra-day and inter-day RSD were less than 11.86% and 8.4% respectively. Conclusion: A sensitive and accurate method suitable for clinical monitoring of plasma galantamine hydrobromide concentration is developed.
出处 《中国新药杂志》 CAS CSCD 北大核心 2003年第10期842-844,共3页 Chinese Journal of New Drugs
关键词 高效液相色谱荧光检测法 加兰他敏 血药浓度 high-performance liquid chromotography with fluorescent detection galanthamine plasma concentration
  • 相关文献

参考文献12

  • 1Mucke HA. Preclinical studies with galanthamine[J ]. Drugs of Today, 1997,33 : 259 - 264.
  • 2Zhao Q, Iyer GR, Verhaeghe T, et al. Pharmacokinetics and safety of galantamine in subjects with hepatic impairment[J]. J Clin Pharmacol,2002,42(4) :428 - 436.
  • 3Farlow MR. Pharmaeokinetie profiles of current therapies for Alzheimer' s disease: implications for switching to galantamine[J]. Clin Ther ,2001,23(Suppl A) :A13 - 24.
  • 4Claessens HA, VanThiel M, Westra P, et al. High-performance liquid ehromatographie determination of galanthamine, a long-acting anticholinesterase drug, in serum, urine and bile[ J ]. J Chromatogr, 1983,275 (2) : 345 - 353.
  • 5Tencheva J, Yamboliev I, Zhivkova Z. Reversed - phase liquid chromatography for the determination of galanthamine and its metabolites in human plasma and urine[J]. J Chromatogr, 1987,421(2) :396 - 400.
  • 6Tanahashi T, Poulev A, Zenk MH. Radioimmunoassay for the quantitative determination of galanthamine [ J ]. Planta Med,1990,56(1) :77 - 81.
  • 7Ingkaninan K, de-Best CM, van-der-Heijden R, et al. High-performance liquid chromatography with on-line coupled UV,mass spectrometric and biochemical detection for identification of acetylcholinesterase inhibitors from natural products [J ]. J Chromatogr A,2000,872(1 - 2) :61 - 73.
  • 8Mihailova D, Yamboliev I. Pharmaeokineties of galanthamine hydrobromide (Nivalin) following single intravenous and oral administration in rats[J]. Pharmacology, 1986,32(6) : 301 - 306.
  • 9Marston A, Kissling J, Hostettmann K. A rapid TLC bioautographic method for the detection of acetylcholinesterase and butyrylcholinesterase inhibitors in plants [ J ]. Phytochem Anal,2002,13(1):51-54.
  • 10Harvey AL. The pharmacology of galanthamine and its analogues[J]. Pharmaco Ther ,1995,68(1) :113 - 128.

同被引文献30

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部